MarketBeat News Feed
Overdue Last read · last published · next check
Last read 7 hours ago, longer than this feed's 1 hour schedule.
Vitesse Energy (NYSE:VTS) President and CEO Jamie Benard outlined the company’s non-operated energy investment model, capital-allocation priorities and approach to maintaining its shareholder dividend during a presentation at an EnerCom event. Benard, who became president and CEO in May, said Denve
Rivian Automotive, Inc. (NASDAQ:RIVN - Get Free Report) CFO Claire Mcdonough sold 8,023 shares of the company's stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $16.00, for a total value of $128,368.00. Following the completion of the transaction, the chief financial officer directly owned 819,178 shares of the company's stock, valued at…
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) insider Mayukh Sukhatme sold 17,519 shares of the business's stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $37.30, for a total value of $653,458.70. Following the completion of the sale, the insider owned 18,630,739 shares of the company's stock, valued at $694,926,564.70. This trade…
GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) major shareholder Francisco Partners Iv, L.P. sold 274,717 shares of the company's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $3.50, for a total transaction of $961,509.50. Following the completion of the sale, the insider directly owned 777,213 shares of the company's stock, valued at…
GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) major shareholder Francisco Partners Iv, L.P. sold 447,259 shares of GoodRx stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $3.52, for a total value of $1,574,351.68. Following the transaction, the insider owned 913,592 shares in the company, valued at approximately $3,215,843.84. This trade…
GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) major shareholder Francisco Partners Iv, L.P. sold 471,975 shares of the business's stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $3.53, for a total transaction of $1,666,071.75. Following the completion of the transaction, the insider owned 1,127,436 shares of the company's stock, valued at…
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) insider Mayukh Sukhatme sold 144,756 shares of the company's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $36.48, for a total transaction of $5,280,698.88. Following the completion of the sale, the insider directly owned 18,630,739 shares of the company's stock, valued at $679,649,358.72. The trade…
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) insider Mayukh Sukhatme sold 172,899 shares of the company's stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $37.17, for a total transaction of $6,426,655.83. Following the transaction, the insider owned 18,630,739 shares of the company's stock, valued at approximately $692,504,568.63. The trade was a…
Spartan Delta (TSE:SDE) is pursuing a production-growth strategy centered on its Duvernay position in Alberta, while using its legacy Deep Basin operations to support cash flow and expand its development inventory, Chief Operating Officer Martin Malek said during an ATB Capital Markets presentation.
Arbutus Biopharma (NASDAQ:ABUS - Get Free Report) announced that its Board of Directors has initiated a stock repurchase plan on Friday, August 21st, RTT News reports. The company plans to buyback $0.00 in outstanding shares. This buyback authorization authorizes the biopharmaceutical company to repurchase shares of its stock through open market purchases. Shares buyback plans are generally a sign…
Canadian Imperial Bank of Commerce raised their price objective on Wesdome Gold Mines from C$32.00 to C$35.00 in a research report on Friday.
Barclays increased their price target on Toronto-Dominion Bank from C$140.00 to C$164.00 in a research note on Friday.
Keefe, Bruyette & Woods set a C$180.00 target price on shares of Toronto-Dominion Bank and gave the stock a "market perform" rating in a research note on Friday.
Keefe, Bruyette & Woods set a C$148.00 price target on shares of Bank of Nova Scotia and gave the company an "outperform" rating in a research report on Friday.
Barclays boosted their price objective on shares of Royal Bank of Canada from C$260.00 to C$300.00 in a report on Friday.
Keefe, Bruyette & Woods set a C$316.00 target price on Royal Bank of Canada and gave the stock a "market perform" rating in a report on Friday.
Barclays increased their price objective on National Bank of Canada from C$188.00 to C$220.00 in a research report on Friday.
Keefe, Bruyette & Woods set a C$186.00 price target on shares of Canadian Imperial Bank of Commerce and gave the stock a "market perform" rating in a research note on Friday.
Barclays increased their price target on shares of Canadian Imperial Bank of Commerce from C$144.00 to C$170.00 in a research note on Friday.
Barclays lifted their price objective on shares of Bank of Nova Scotia from C$110.00 to C$130.00 in a report on Friday.
AJ Bell (LON:AJB) Trading Up 1% - What's Next?
Mesa Air Group (NASDAQ:RJET) Trading Down 3% - What's Next?
Fabrinet (NYSE:FN) executives said demand across data center interconnect, datacom, automotive and industrial markets remains strong, with the company expanding manufacturing capacity to support what Chairman and CEO Seamus Grady described as substantial multi-year growth opportunities. Speaking at
Mobia Medical, Inc. (NASDAQ:MOBI - Get Free Report) Director Casey Tansey acquired 16,441 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was acquired at an average cost of $12.07 per share, with a total value of $198,442.87. Following the completion of the purchase, the director owned 318,332 shares of the company's stock, valued at $3,842,267.24. This trade…
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CAO Ryan Bartolucci sold 6,175 shares of the company's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $49.61, for a total transaction of $306,341.75. Following the sale, the chief accounting officer directly owned 67,866 shares in the company, valued at approximately $3,366,832.26. This trade represents…
Flex Ltd. (NASDAQ:FLEX - Get Free Report) insider Michael Hartung sold 2,755 shares of the business's stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $120.64, for a total value of $332,363.20. Following the sale, the insider owned 243,175 shares in the company, valued at approximately $29,336,632. This represents a 1.12% decrease in their…
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) EVP Andrew Polovin sold 7,927 shares of Tempus AI stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $56.00, for a total transaction of $443,912.00. Following the completion of the sale, the executive vice president directly owned 138,140 shares in the company, valued at approximately $7,735,840. The trade…
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) EVP Andrew Polovin sold 22,148 shares of the business's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $49.61, for a total value of $1,098,762.28. Following the completion of the transaction, the executive vice president directly owned 146,067 shares in the company, valued at approximately $7,246,383.87. This…
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CFO James William Rogers sold 22,529 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $49.61, for a total value of $1,117,663.69. Following the sale, the chief financial officer owned 132,337 shares in the company, valued at approximately $6,565,238.57. This trade represents a 14.55%…
American Vanguard Corporation (NYSE:AVD - Get Free Report) Director Keith Rosenbloom sold 556,580 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $2.20, for a total value of $1,224,476.00. Following the completion of the transaction, the director directly owned 15,201 shares in the company, valued at $33,442.20. This trade represents a…